Company intelligence / Profile preview

Alsana

Thousand Oaks, California, United States

Ownership: Private
Development stage: Other

Overview

Alsana reports industry-leading outcomes for eating disorder treatment, with statistically significant improvements in eating disorder symptoms, quality of life, anxiety, depression, trauma, and emotion regulation. In 2023, 91% of clients found virtual care comprehensive and adaptive, while 97% would recommend the program; large effect sizes were recorded for key clinical outcomes[7].

Therapeutic areas: EndocrinologyPsychiatry
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Alsana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alsana.

Explore the full profile